Vascular tone can be regulated via nucleotides like ATP and UTP that are derived from erythrocytes or platelets or released from the endothelium (Ralevic & Burnstock 2003). It is known that ATP is an agonist of P2Y2 receptors and UTP is an agonist of P2Y2/4 receptors (Abbracchio et al. 2006). A decrease in blood pressure most likely results from ATP inducing endothelium-dependent relaxation (von Kugelgen et al. 1987, von Kugelgen & Starke 1990, Ralevic & Burnstock 1991a, 2003). Evidence suggests that this vasodilatory response can be mediated by nitric oxide (NO; Ralevic & Burnstock 1991a), endothelial-derived hyperpolarization (EDH; Malmsjo et al. 1999, 2002, Wihlborg et al. 2003) and/or prostacyclin (Hammer et al. 2003, Wihlborg et al. 2003). P2Y2 receptors are found on the endothelium and it was proposed that their activation stimulates the synthesis and release of NO (Ralevic & Burnstock 1991b, Buvinic et al. 2002, Burnstock 2009). Moreover, aortic rings from P2Y2 receptor knockout mice (P2Y2−/−) exhibit impaired vasorelaxation in response to ATP, which suggests that NO release is subsequent to P2Y2 receptor activation (Guns et al. 2005, 2006). Of note, mechanical destruction of the endothelium abolishes the ATP induced vasodilatory effect and produces a direct vasoconstrictory response on vascular smooth muscle cells (Kennedy & Burnstock 1985, Kennedy et al. 1985, Ralevic & Burnstock 1996b). Activation of P2Y4 receptors is associated with vasoconstriction (Dietrich et al. 1996, McMillan et al. 1999, Rubino et al. 1999). In contrast to ATP causing vasodilation, UTP was found to vasoconstrict mouse aortic rings (Boarder & Hourani 1998, Kauffenstein et al. 2010) and rabbit inner ear arteries (von Kugelgen et al. 1987). However, depending on route of administration, species, localization within the vascular tree or vessel type, UTP can cause vasoconstriction, vasodilation or both (Ralevic & Burnstock 1996a,b, Janigro et al. 1997, Horiuchi et al. 2001, Guns et al. 2005, Rayment et al. 2007, Inscho 2009). In recent studies, we demonstrated that P2Y2 receptors play a physiological role in blood pressure regulation and, as a consequence, P2Y2−/− mice were found to have salt-resistant hypertension (Rieg et al. 2007a, Pochynyuk et al. 2010). Direct intra-arterial blood pressure measurements indicated that the blood pressure responses to a P2Y2/4 agonist result in vasodilation via a NO-independent mechanism that possibly involves EDH release subsequently to P2Y2 receptor activation. This was concluded because endothelial NO synthase knockout mice (eNOS−/−) showed an identical blood pressure effect in response to P2Y2/4 receptor activation compared to WT mice. In contrast to WT mice, P2Y2−/− mice responded to P2Y2/4 receptor activation with an increase in blood pressure, possibly a direct effect of P2Y4 receptor activation on vascular smooth muscle cells, which is independent of P2Y2 receptors (Rieg et al. 2011). The vasodilation mediated by EDH requires activation of calcium-activated potassium channels, including KCa2.3 (small-conductance) and KCa3.1 (intermediate-conductance), which are expressed in most endothelial cells (Kohler & Ruth 2010). In contrast, KCa1.1 (big-conductance) is expressed in vascular smooth muscle cells (Feletou 2009, Kohler & Ruth 2010). The activation of calcium-activated potassium channels is speculated to produce hyperpolarization of the endothelium, which is then transmitted (possibly via connexins, see below) to underlying vascular smooth muscle cells causing vasodilation via EDH. Functional studies employing blockers of calcium-activated potassium channels have demonstrated the role of these channels in EDH and subsequent vascular smooth muscle relaxation (Adeagbo & Triggle 1993, Holzmann et al. 1994, Waldron & Garland 1994, Zygmunt & Hogestatt 1996, Eichler et al. 2003). Vascular smooth muscle cells and endothelial cells are functionally linked, and the point of contact between the two cells, the myoendothelial gap junction (MEGJ), plays a key role in the regulation of vascular function (Figueroa & Duling 2009). Initially, it was assumed that a diffusible endothelial factor was the mechanism resulting in hyperpolarization; however, this view was later questioned by experiments demonstrating the involvement of the MEGJ (Griffith et al. 2002, Dora et al. 2003, Chaytor et al. 2005, Mather et al. 2005, Sokoya et al. 2006). It was concluded from these studies that EDH is transferred from the endothelium to the smooth muscle by direct charge transfer through the MEGJ (de Wit & Wolfle 2007, Feletou & Vanhoutte 2009, Grgic et al. 2009, Edwards et al. 2010, de Wit & Griffith 2010, Garland et al. 2011). Gap junction proteins found in the vasculature include as follows: Cx37, Cx40, Cx43 and Cx45 (Figueroa et al. 2004, Lohman et al. 2012); however, the MEGJ is specifically comprised of Cx37 and Cx40 which are speculated to conduct the EDH response as an electrical signal between endothelial and vascular smooth muscle cells (Chaytor et al. 2005, Isakson & Duling 2005, Haddock et al. 2006). To further define the underlying mechanism(s) involved in the P2Y2 receptor-initiated blood pressure responses, possibly via EDH, we studied blood pressure and heart rate in WT, Cx37, Cx40, KCa1.1 and KCa3.1 knockout (−/−) mice in response to systemic application of a P2Y2/4 receptor agonist. We report that P2Y2/4 receptor activation generates a similar biphasic blood pressure response in all mice except for KCa3.1−/− and Cx37−/− mice, which show impaired vascular reactivity. This implies that both KCa3.1 and Cx37 are required for full vascular reactivity in response to P2Y2/4 receptor activation.